Understanding the “Skin Sensitivity” Phenomenon

A small percentage of patients report that their skin feels tender or “achy” to the touch after starting semaglutide or tirzepatide.

This isn’t a typical allergy or rash. It’s usually related to GLP-1 receptors on sensory nerves that temporarily adjust as glucose levels and inflammatory signals stabilize.

Other possible contributors include:

• Rapid shifts in blood sugar during early treatment
  

• Nutrient deficiencies (especially B12, B6, magnesium) as appetite drops
  

• Viral reactivation like shingles, which can mimic neuropathic pain
  
  

The sensitivity typically resolves within a few weeks. If accompanied by a rash or burning, your provider should rule out shingles or contact dermatitis.

Muscle Loss: What’s Real and What’s Preventable

GLP-1s promote rapid fat loss—and whenever weight comes off quickly, some lean tissue can decline.

But the narrative that “GLP-1s eat muscle” is misleading. Studies show most muscle changes mirror those from any calorie deficit, not a drug-specific effect.

To preserve muscle:

• Prioritize protein (≥1 g per lb of lean body weight)
  

• Add resistance training 2–3×/week
  

• Consider peptides like CJC + Ipamorelin or creatine to support IGF-1 signaling and recovery
  
  

At DrBrainRx, we actively protect muscle through targeted peptide stacks and nutrition plans.

The Takeaway

Tender skin usually passes, and muscle loss is avoidable. The key is slow titration, nutrient support, and consistent strength training.

Start a balanced, monitored GLP-1 plan at drbrainrx.com.

References

1. Jastreboff AM et al. NEJM. 2022; 387:205–216.
   

2. Wilding JPH et al. NEJM. 2021; 384:989–1002.

3. Finlayson G et al. Nat Metab. 2024.